Large-scale testing (Phase 3)WithdrawnNCT06260748
What this trial is testing
Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
Who this might be right for
Cerebrotendinous Xanthomatoses
Leadiant Biosciences, Inc.